Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of pioglitazone and metformin
combination therapy, once daily (QD), on glycosylated hemoglobin in adults with type 2
diabetes.